Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01577706 · ClinicalTrials.gov registry record · NA
Spectroscopic Imaging at 4T: A Drug Challenge Study
A NA study, sponsored by Mclean Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT01577706 is a NA study that was terminated before completion, run by Mclean Hospital. The registered enrollment target is 7 participants.
The verdict
NCT01577706, a NA study, was terminated before completion, sponsored by Mclean Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
An advanced technique for rapid magnetic resonance proton spectroscopic imaging (1H-MRSI) will be employed in a drug challenge study in healthy volunteers to spatially map and measure acute changes in the brain chemicals GABA, glutamate and glutamine after administration of a drug. Three condition will be tested in a double-blind fashion, i)depressant, ii)stimulant, iii)placebo. It is hypothesized that unique and reproducible spatial and directional metabolic response patterns will be observed, unique to each condition within the brain.
Interventions
- OTHER Placebo
- DRUG Alprazolam
- DRUG Dextroamphetamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2013-06 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01577706
The ClinicalTrials.gov registry entry for NCT01577706 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mclean Hospital, which has 140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01577706 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01577706 about?
NCT01577706 is a clinical study titled "Spectroscopic Imaging at 4T: A Drug Challenge Study". An advanced technique for rapid magnetic resonance proton spectroscopic imaging (1H-MRSI) will be employed in a drug challenge study in healthy volunteers to spatially map and measure acute changes in the brain chemicals GABA, glutamate and glutamine after administration of a drug. Three condition w...
What is the current status of trial NCT01577706?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2013-06. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01577706?
The interventions under investigation include: Placebo (OTHER), Alprazolam (DRUG), Dextroamphetamine (DRUG).
Who is sponsoring clinical trial NCT01577706?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.